CD95/Fas and metastatic disease: What does not kill you makes you stronger

Volume: 60, Pages: 121 - 131
Published: Feb 1, 2020
Abstract
CD95 (also known as Fas) is the prototype of death receptors; however, evidence suggests that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB, MAPK, and PI3K that are involved in cell migration, differentiation, survival, and cytokine secretion. At least two different forms of CD95 L exist. The multi-aggregated transmembrane ligand (m-CD95 L) is cleaved by metalloproteases to release a homotrimeric soluble ligand...
Paper Details
Title
CD95/Fas and metastatic disease: What does not kill you makes you stronger
Published Date
Feb 1, 2020
Volume
60
Pages
121 - 131
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.